Cargando…
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
BACKGROUND: Coronavirus disease-19 (COVID-19) is an infectious disease transmitted by the virus responsible for the severe acute respiratory syndrome 2 (SARS-CoV-2), which exhibit several clinical manifestations including gastrointestinal symptoms. SCOPE AND APPROACH: This review aimed to provide in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720301/ https://www.ncbi.nlm.nih.gov/pubmed/35002079 http://dx.doi.org/10.1016/j.tifs.2021.12.033 |
_version_ | 1784625109793767424 |
---|---|
author | Xavier-Santos, Douglas Padilha, Marina Fabiano, Giovanna Alexandre Vinderola, Gabriel Gomes Cruz, Adriano Sivieri, Katia Costa Antunes, Adriane Elisabete |
author_facet | Xavier-Santos, Douglas Padilha, Marina Fabiano, Giovanna Alexandre Vinderola, Gabriel Gomes Cruz, Adriano Sivieri, Katia Costa Antunes, Adriane Elisabete |
author_sort | Xavier-Santos, Douglas |
collection | PubMed |
description | BACKGROUND: Coronavirus disease-19 (COVID-19) is an infectious disease transmitted by the virus responsible for the severe acute respiratory syndrome 2 (SARS-CoV-2), which exhibit several clinical manifestations including gastrointestinal symptoms. SCOPE AND APPROACH: This review aimed to provide insights and perspectives for the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention/treatment and/or modulation of the microbiota in COVID-19 patients. Eighty-four studies published in the Scopus database from the onset of the pandemic until December 2021 were assessed and submitted to a bibliometric analysis adapted from VOSviewer software. KEY FINDINGS AND CONCLUSIONS: Through bibliometric analysis, it might be suggested that the modulation of the gut/lung microbiome is promising as an adjuvant for the prevention/treatment of COVID-19 patients, due to immunomodulation properties related to probiotics and prebiotics. So far, few clinical studies involving the application of probiotics in COVID-19 patients have been completed, but reduction in the duration of the disease and the severity of symptoms as fatigue, olfactory dysfunction and breathlessness, nausea and vomiting and other gastrointestinal symptoms were some of the main findings. However, probiotics are not recommended to immunocompromised patients in corticosteroid therapy. The future perspectives point to the modulation of the intestinal microbiota by probiotics, prebiotics, synbiotics, and postbiotics represent a promising adjuvant approach for improving the health of patients with COVID-19. |
format | Online Article Text |
id | pubmed-8720301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87203012022-01-03 Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review Xavier-Santos, Douglas Padilha, Marina Fabiano, Giovanna Alexandre Vinderola, Gabriel Gomes Cruz, Adriano Sivieri, Katia Costa Antunes, Adriane Elisabete Trends Food Sci Technol Article BACKGROUND: Coronavirus disease-19 (COVID-19) is an infectious disease transmitted by the virus responsible for the severe acute respiratory syndrome 2 (SARS-CoV-2), which exhibit several clinical manifestations including gastrointestinal symptoms. SCOPE AND APPROACH: This review aimed to provide insights and perspectives for the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention/treatment and/or modulation of the microbiota in COVID-19 patients. Eighty-four studies published in the Scopus database from the onset of the pandemic until December 2021 were assessed and submitted to a bibliometric analysis adapted from VOSviewer software. KEY FINDINGS AND CONCLUSIONS: Through bibliometric analysis, it might be suggested that the modulation of the gut/lung microbiome is promising as an adjuvant for the prevention/treatment of COVID-19 patients, due to immunomodulation properties related to probiotics and prebiotics. So far, few clinical studies involving the application of probiotics in COVID-19 patients have been completed, but reduction in the duration of the disease and the severity of symptoms as fatigue, olfactory dysfunction and breathlessness, nausea and vomiting and other gastrointestinal symptoms were some of the main findings. However, probiotics are not recommended to immunocompromised patients in corticosteroid therapy. The future perspectives point to the modulation of the intestinal microbiota by probiotics, prebiotics, synbiotics, and postbiotics represent a promising adjuvant approach for improving the health of patients with COVID-19. Elsevier Ltd. 2022-02 2022-01-02 /pmc/articles/PMC8720301/ /pubmed/35002079 http://dx.doi.org/10.1016/j.tifs.2021.12.033 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Xavier-Santos, Douglas Padilha, Marina Fabiano, Giovanna Alexandre Vinderola, Gabriel Gomes Cruz, Adriano Sivieri, Katia Costa Antunes, Adriane Elisabete Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review |
title | Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review |
title_full | Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review |
title_fullStr | Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review |
title_full_unstemmed | Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review |
title_short | Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review |
title_sort | evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of covid-19: a bibliometric analysis and systematic review |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720301/ https://www.ncbi.nlm.nih.gov/pubmed/35002079 http://dx.doi.org/10.1016/j.tifs.2021.12.033 |
work_keys_str_mv | AT xaviersantosdouglas evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview AT padilhamarina evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview AT fabianogiovannaalexandre evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview AT vinderolagabriel evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview AT gomescruzadriano evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview AT sivierikatia evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview AT costaantunesadrianeelisabete evidencesandperspectivesoftheuseofprobioticsprebioticssynbioticsandpostbioticsasadjuvantsforpreventionandtreatmentofcovid19abibliometricanalysisandsystematicreview |